Archives of “Education” category

rss

Alfaazo K Fakir / अल्फ़ाज़ों के फ़क़ीर (Hindi) -#AnirudhSethi

  
Analysis, Education, Life

“Love is never outdated, it keeps updating with the time.”

This is all I want to convey through my book “Alfaazo K Fakir”. It is a complete package of feelings, thoughts, imaginations and some of the real stories that I have seen in the society and surrounding in my poetic way.

I haven’t written any poetries I just have tried to pen down some of the real stories that I have seen in my life and others too, some of them I have felt for me and some in the other people.

Basically, it’s a glimpse of the love that occurs in the face and heart of the people who are in love, were in love or they are just thinking of love.

You may have seen people sad when they broke up, happy when they patch up, lost in the deep and beautiful eyes of their lover, talking senseless in the absence of the paramour, amazed and blessed after meeting , totally lurked in the emotional river after their first kiss, drinking after seeing some bitter phase, etc. This is all that I have also examined in the different people and that I have written in this.

I am not that perfect and mature in this segment as I said, but I am feeling ful. I request you all to shower your love by reading my thoughts and experiences interlaced in the form of poetry.

A market perspective: How the race for a COVID-19 vaccine will affect pharmaceutical companies

  
Analysis, Education

Ever since the COVID-19 virus emerged and evolved into a global pandemic, investors have shifted their focus away from small biotech firms to larger pharmaceuticals with robust and structured manufacturing capabilities.

Once the COVID-19 vaccine is discovered, it may generate in excess of $10 billion dollars in annual revenue, but investors are betting that even if a small biotech company with limited funding and equipment discovers the vaccine, a larger company will most likely buy the drug from them.

Alternatively, the smaller company that discovered the drug and the larger company with the production and distribution capability could merge.

Gilead and Eli Lilly, two of the pharmaceutical companies taking center stage in the COVID-19 vaccine race, are foreseeing significant growth in their share value and a rise in innovation in the infectious disease area.

AstraZeneca’s growth in China took a hit given the Chinese economic situation due to the outbreak, and even more so in the EU and the US where large fractions of AstraZeneca’s total revenue is generated. Therefore, AZ joined with Sanofi in an effort to find a vaccine, which will eventually help them regain some of their losses. (more…)

Go to top